MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

GlaxoSmithKline

  • FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine
    A committee of outside advisers to the U.S. Food and Drug Administration (FDA) recommended a vaccine from GlaxoSmithKline (GSK) against the respiratory syncytial virus (RSV) for adults over age 60. The ...
    March 2, 2023BY Mimi Nguyen Ly
  • Biden Administration Stops Shipments of COVID-19 Treatment to All States
    Biden Administration Stops Shipments of COVID-19 Treatment to All States
    The U.S. government on April 5 immediately halted all shipments of a COVID-19 treatment to states and ordered ...
    April 6, 2022BY Zachary Stieber
  • GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead
    Britain's GlaxoSmithKline will receive $1.25 billion from Gilead Sciences as part of a settlement between its HIV medicines ...
    February 3, 2022BY Reuters
  • Treat COVID-19 Like ‘Common Cold,’ Says British Trust, While Pledging $22 Billion for Vaccine Research
    Treat COVID-19 Like ‘Common Cold,’ Says British Trust, While Pledging $22 Billion for Vaccine Research
    Pandemic-related lockdowns are no longer practical, according to the UK's largest charitable foundation focused on health research, which ...
    January 13, 2022BY Naveen Athrappully
  • Glaxo Says Its COVID-19 Antibody Treatment Effective Against Omicron
    Glaxo Says Its COVID-19 Antibody Treatment Effective Against Omicron
    British drugmaker GlaxoSmithKline said early-stage lab data shows its COVID-19 monoclonal antibody treatment, jointly developed with U.S. partner ...
    December 7, 2021BY Tom Ozimek
  • Florida Acquires Monoclonal Antibodies From GlaxoSmithKline After Biden Administration’s Rationing
    Florida Acquires Monoclonal Antibodies From GlaxoSmithKline After Biden Administration’s Rationing
    The state of Florida has obtained thousands of monoclonal antibody treatments to treat COVID-19 from a UK-based company ...
    September 23, 2021BY Zachary Stieber
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK
    Swiss authorities have agreed to extradite a Chinese researcher to the United States, where he is accused of ...
    July 17, 2019BY Frank Fang
  • US Seeks Extradition of Chinese Researcher in Drug Secrets Theft
    US Seeks Extradition of Chinese Researcher in Drug Secrets Theft
    ZURICH—The United States wants Switzerland to extradite a Chinese researcher accused of helping his scientist sister steal secrets ...
    July 8, 2019BY Reuters
  • GSK Chairman Hampton to Step Down Ahead of Split
    GSK Chairman Hampton to Step Down Ahead of Split
    GlaxoSmithKline Plc. Chairman Philip Hampton will step down after more than three and a half years in the ...
    January 22, 2019BY Reuters
  • Chinese Scientist Pleads Guilty to Conspiracy to Steal Trade Secrets From Drug Giant GlaxoSmithKline
    Chinese Scientist Pleads Guilty to Conspiracy to Steal Trade Secrets From Drug Giant GlaxoSmithKline
    This is the latest in a string of cases involving Chinese nationals conducting science and tech-related espionage beneficial ...
    September 16, 2018BY Annie Wu
  • Drugmaker GSK to Eliminate 650 US Jobs
    Drugmaker GSK to Eliminate 650 US Jobs
    British drugmaker GlaxoSmithKline Plc said on Sept. 5 it would cut about 650 positions in the United States ...
    September 5, 2018BY Reuters
  • Veteran Bowler Aims for National Glory
    Veteran Bowler Aims for National Glory
    HONG KONG—Veteran bowler David Tso is on course for his first national trophy since 1998, after defeating a ...
    March 4, 2015BY Claudius Lam
  • Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?
    Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?
    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined ...
    January 6, 2015BY Morningstar
  • British Private Eye in China Prosecuted for Knowing Too Much
    British Private Eye in China Prosecuted for Knowing Too Much
    A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information ...
    July 14, 2014BY Matthew Robertson
TOP NEWS
  • New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
    1hr By Zachary Stieber
    New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
  • Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
    1hr By Jack Phillips
    Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
  • Trump-Ordered Vaccine Safety Report Delayed Past Deadline
    2hr By Zachary Stieber
    Trump-Ordered Vaccine Safety Report Delayed Past Deadline
  • Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
    2hr By Evgenia Filimianova
    Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
  • Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
    3hr By Frank Fang
    Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
  • Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
    3hr By Andrew Moran
    Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
  • US Denies Iran’s Claim It Destroyed Radar in Bahrain
    3hr By Evgenia Filimianova
    US Denies Iran’s Claim It Destroyed Radar in Bahrain
  • IRS Collected Over $5.5 Trillion in Federal Taxes in 2026
    4hr By Naveen Athrappully
    IRS Collected Over $5.5 Trillion in Federal Taxes in 2026
  • Microsoft Reports Progress Fixing Global Outage Impacting Millions
    4hr By Chris Summers
    Microsoft Reports Progress Fixing Global Outage Impacting Millions
  • RFK Jr. Announces Funding to Study Ibogaine Psychedelic Drug
    5hr By Zachary Stieber
    RFK Jr. Announces Funding to Study Ibogaine Psychedelic Drug
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top